149 results
8-K
EX-10.1
OPGN
Opgen Inc
16 Apr 24
Departure of Directors or Certain Officers
7:22pm
Entities”), or clients, including without limitation any of their actual or anticipated business, research or development, any of their technology … such Creation (i) relates in any way to the business or to the current or anticipated research or development of the Company or any of its Affiliated
SC 14F1
OPGN
Opgen Inc
3 Apr 24
Statement regarding change in majority of directors
5:29pm
of the Scientific Advisory Committee of the Global Antibiotic Research and Development Partnership (GARDP), a DNDi/WHO initiative, the Chairperson of the Clinical … of Cologne.
Johannes Bacher. Mr. Bacher has over 20 years of research and development and managerial experience along with extensive expertise
8-K
EX-10.1
OPGN
Opgen Inc
29 Mar 24
OpGen Announces Acquisition of Preferred Stock by David Lazar
2:35pm
, records, data, know-how, techniques, designs, machinery, devices, research and development projects, data, preparations, business forms, strategies
8-K
EX-10.4
OPGN
Opgen Inc
29 Mar 24
OpGen Announces Acquisition of Preferred Stock by David Lazar
2:35pm
, machinery, devices, research and development projects, data, preparations, business forms, strategies, plans for development of products, services
8-K
EX-99.1
OPGN
Opgen Inc
14 Nov 23
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
4:40pm
Research and development
General and administrative
Sales and marketing
Goodwill impairment charge
Total operating expenses
Operating loss
Other
8-K
EX-99.1
qrfwzgvetmo5a
10 Aug 23
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
4:31pm
8-K
EX-99.1
moggf 0o7n9ydw6ik
15 May 23
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
5:11pm
8-K
EX-99.1
gyxbu
4 May 23
OpGen Announces Pricing of $3.5 Million Public Offering
4:47pm
8-K
EX-99.2
4otss9c6q1s00v8wo
4 May 23
OpGen Announces Pricing of $3.5 Million Public Offering
4:47pm
8-K
esw9jyu l9ym760glq
4 May 23
OpGen Announces Pricing of $3.5 Million Public Offering
4:47pm
424B3
utalnlu0 uw0n
3 May 23
Prospectus supplement
4:43pm